1 completed, 1 recruiting. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Recruiting 1 |
Follow Polycythemia Vera (PV): new trials by email Literature Review of Polycythemia Vera (PV) trials Research Report on Polycythemia Vera (PV)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate P1101 in Japanese PV Patients P1101, Low-dose aspirin, Phlebotomy - Polycythemia Vera (PV) | Phase 3 | Completed | PharmaEssentia Japan K.K. | 21 | 2023-10-17 | 2024-11-08 |
| Extension Study of P1101 After Completion of Phase 2 Study in PV Patients or Phase 3 Study in ET Patients P1101 (Ropeginterferon alfa-2b) - Polycythemia Vera (PV) | Phase 3 | Recruiting | PharmaEssentia Japan K.K. | 67 | 2021-01-19 | 2024-11-08 |
Myeloproliferative Disorders (2) · Polycythemia Vera (2)
Bone Marrow Diseases (2) · Bone Marrow Neoplasms (2) · Hematologic Diseases (2) · Hematologic Neoplasms (2) · Hemic and Lymphatic Diseases (2) · Neoplasms (2) · Neoplasms by Site (2)
Aspirin (1) · Phlebotomy (1)
Japan (2)
Keita Kirito, MD (1)